Agios Pharmaceuticals AGIO
NASDAQ AGIO
$33.25 -0.05 (-0.15%)
At close: Sep 30, 2026 · 4:00 PM EDT

Agios Pharmaceuticals (AGIO) Total Non-Current Liabilities (2012 - 2026)

Updated

Agios Pharmaceuticals (AGIO) posted Total Non-Current Liabilities of $82.16 million for Q2 2026, down 19.1% from $101.58 million a year earlier but up 8.4% from the prior quarter.

Analysis

Agios Pharmaceuticals (AGIO) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends

At the end of FY2025, Agios Pharmaceuticals' Total Non-Current Liabilities came in at $104.02 million, down 14.3% from FY2024.

  • Annual Total Non-Current Liabilities has declined for four consecutive years, with a four-year compound annual growth rate of -8.1% (FY2021 to FY2025).
  • In prior years, Agios Pharmaceuticals' Total Non-Current Liabilities was $121.36 million in FY2024 (-2.9%), $124.94 million in FY2023 (-7.2%), $134.63 million in FY2022 (-7.6%) and $145.76 million in FY2021.
  • Quarterly Total Non-Current Liabilities has run from a low of $75.79 million in Q1 2026 to a high of $163.97 million in Q3 2024 over five years.
  • On a year-over-year basis, Total Non-Current Liabilities has declined in each of the last seven quarters, with an average decline of 9.5% over the last eight quarters.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q3 2024, with growth of 37.5%; the weakest was Q3 2025, with a decline of 38.2%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $75.79 million (Q1 2026), $104.02 million (Q4 2025) and $101.29 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Agios Pharmaceuticals 1.98 Bn 1.98 Bn 41.75 Mn 82.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 82.16 Mn
Mar 31, 2026 75.79 Mn
Dec 31, 2025 104.02 Mn
Sep 30, 2025 101.29 Mn
Jun 30, 2025 101.58 Mn
Mar 31, 2025 88.11 Mn
Dec 31, 2024 121.36 Mn
Sep 30, 2024 163.97 Mn
Jun 30, 2024 111.40 Mn
Mar 31, 2024 104.63 Mn
Dec 31, 2023 124.94 Mn
Sep 30, 2023 119.26 Mn
Jun 30, 2023 119.76 Mn
Mar 31, 2023 113.46 Mn
Dec 31, 2022 134.63 Mn
Sep 30, 2022 129.10 Mn
Jun 30, 2022 127.34 Mn
Dec 31, 2021 145.76 Mn
Jun 30, 2020 417.19 Mn
Mar 31, 2020 173.87 Mn
API Access

Agios Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=AGIO&period=max&api_key=YOUR_API_KEY